This Article Full Text Full Text (PDF) All Versions of this Article: 36/5/965    most recent 01.STR.0000163104.92943.50v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Carod-Artal, F. J. Articles by Nunes, L. G. N. Search for Related Content PubMed PubMed Citation Articles by Carod-Artal, F. J. Articles by Nunes, L. G. N. Pubmed/NCBI databases Medline Plus Health Information Cardiomyopathy Chagas Disease Stroke Related Collections Epidemiology Thrombophilia Embolic stroke Risk Factors for Stroke

(Stroke. 2005;36:965.)
© 2005 American Heart Association, Inc.

Original Contributions

Chagasic Cardiomyopathy Is Independently Associated With Ischemic Stroke in Chagas Disease

From the Department of Neurology, The Sarah Network of Hospitals of Rehabilitation, Sarah Hospital, Brasilia DF, Brazil.

Correspondence to Francisco Javier Carod-Artal, MD, PhD, Neurology Department. Sarah Hospital SMHS quadra 501 conjunto A, CEP 7330–150, Brasilia DF, Brazil. E-mail javier{at}bsb.sarah.br or FJCarod@aol.com

Background and Purpose— Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. American trypanosomiasis, Chagas disease (CD), is a major public health problem in South America. We sought to evaluate prevalence of vascular risk factors for stroke in patients with stroke caused by CD.

Methods— Ninety-four consecutive CD stroke patients and 150 consecutive nonchagasic stroke patients were studied. CD was confirmed when both immunofluorescence and hemagglutination serology were positive. Data collected included age, sex, vascular risk factors, diagnostic stroke subtype (TOAST classification), and echocardiography findings. Fasting plasma levels of protein C, protein S, antithrombin III, homocysteine, activated protein C resistance, IgG anticardiolipin antibodies, lupus anticoagulant, and genetic tests for the factor V Leiden and the C677T methylene tetrahydrofolate reductase gene mutation were determined.

Results— CD patients had a mean age of 56.31 years compared with 61.59 years for non-CD stroke patients (P=0.0002). Cardioembolism occurred in 56.38% of CD stroke patients compared with 9.33% in controls (P=0.000), whereas atherothrombotic strokes occurred in 8.51% of CD strokes versus 20% in controls (P=0.016), and small-vessel stroke in 9.57% of CD stroke patients versus 34.67% in controls (P=0.000). Apical aneurysm (37.23% versus 0.67%; OR, 88.39), left ventricular dilatation (23.4% versus 5.33%; OR, 5.42), mural thrombus (11.7 versus 2%; OR, 6.49) and abnormal electrocardiography (ECG) (66% versus 23.33%; OR, 2.87) were significantly higher in the group of chagasic stroke patients. No statistical differences were observed in thrombophilia between both groups. The significant variables that predicted CD stroke patients on a stepwise logistical regression model were apical aneurysm, cardiac insufficiency, ECG arrhythmia, female gender, and hypertension.

Conclusions— Chagasic cardiomyopathy is independently associated with ischemic stroke, whereas hypercoagulable states do not appear to be major contributors to the excess stroke risk seen in patients with CD.

Key Words: aneurysm • Chagas disease • stroke • thrombophilia